BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 24.50
+1.45 (6.29%)
Sep 2, 2026, 5:29 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 1.52 billion as of September 2, 2026. Its market cap has decreased by -25.76% in one year.
Market Cap
1.52B
Enterprise Value
1.20B
Revenue
32.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.50
ChartMarket Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 1.52B, an increase of 25.89%. That is a compound annual growth rate of 0.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.52B | -21.60% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Egetis Therapeutics AB | 3.65B |
| Vicore Pharma Holding AB | 2.91B |
| Saniona AB | 1.58B |
| Flerie AB | 1.56B |
| Genovis AB (publ.) | 1.49B |
| Medivir AB | 1.21B |
| SynAct Pharma AB | 1.12B |
| AlzeCure Pharma AB | 1.02B |